Docoh
Loading...

CYTR Cytrx

CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA.

Company profile

Ticker
CYTR
Exchange
Website
CEO
Steven A. Kriegsman
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
581642750

CYTR stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

24 Mar 21
17 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Cytrx earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 10M 10M 10M 10M 10M 10M
Cash burn (monthly) 866.17K 510.59K 474.26K 569.1K 866.17K 511.68K
Cash used (since last report) 3.09M 1.82M 1.69M 2.03M 3.09M 1.82M
Cash remaining 6.91M 8.18M 8.31M 7.97M 6.91M 8.18M
Runway (months of cash) 8.0 16.0 17.5 14.0 8.0 16.0

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
14 Aug 20 Earl W Brien Common Stock, par value $0.001 per share Option exercise Aquire M No No 0.26 150,000 39K 590,247
14 Aug 20 Earl W Brien Stock Option CytRx Common Stock Option exercise Dispose M No No 0.26 150,000 39K 300,000
7 Aug 20 Joel K Caldwell Common Stock, par value $0.001 per share Payment of exercise Dispose F No No 0.67 174,627 117K 335,373
7 Aug 20 Joel K Caldwell Common Stock, par value $0.001 per share Option exercise Aquire M No No 0.26 450,000 117K 510,000
7 Aug 20 Joel K Caldwell Stock Option CytRx Common Stock Option exercise Dispose M No No 0.26 450,000 117K 0
7 Aug 20 Louis Ignarro Common Stock, par value $0.001 per share Payment of exercise Dispose F No No 0.67 271,642 182K 600,785
7 Aug 20 Louis Ignarro Common Stock, par value $0.001 per share Option exercise Aquire M No No 0.26 700,000 182K 872,427
7 Aug 20 Louis Ignarro Stock Option CytRx Common Stock Option exercise Dispose M No No 0.26 700,000 182K 0
7 Aug 20 Steven A Kriegsman Common Stock, par value $0.001 per share Payment of exercise Dispose F No No 0.67 1,164,179 780K 3,668,038
7 Aug 20 Steven A Kriegsman Common Stock, par value $0.001 per share Option exercise Aquire M No No 0.26 3,000,000 780K 4,832,217

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change

Financial report summary

?
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg
New words: antidilutive, approach, authoritative, Celgene, depositary, dividing, endanger, evidenced, German, IBM, jeopardize, lieu, lowest, MIPLYFFA, multiplied, NantKwest, neurodegenerative, possession, recalculated, regular, remotely, subdivision, subscribe, subscription, threshold, today, tradename, virtually
Removed: accrual, acute, allocable, autoimmune, chronic, decreased, depressed, distinction, distinguishing, distributed, Document, Eric, float, fourteen, HTGC, inflammatory, initially, Instruction, investing, joining, Kratz, lender, Linkbase, literature, LLP, Master, opening, originally, planning, prepaid, production, ranged, ratably, remained, represented, representing, retrospective, Schema, Taxonomy, transition, unit, USA, viral, XBRL